Edward Kim

University of California Davis Medical Center

Also affiliated with Walker (United States), UC Davis Comprehensive Cancer Center, University of California, Davis, The University of Texas at Austin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial”.

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial

Nature Medicine(2024)10.1038/s41591-023-02717-6

N/A

2.0DataRank · unranked

94 citations

Marwan Fakih, John H. Strickler, Rona Yaeger, Toshiki Masuishi, Edward Kim +14 more

Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma

Investigational New Drugs(2021)10.1007/s10637-020-01044-8

N/A

1.6DataRank · unranked

46 citations

Tricia Kunst, Santhana Webb, Christina DeVisser, Christy Arrowood, Seth M. Steinberg +4 more

The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report

Frontiers in Oncology(2020)10.3389/fonc.2020.00581

N/A

0DataRank · unranked

3 citations

Jingran Ji, James Liu, Manmeet Kaur, Edward Kim, Jun Gong +9 more

SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment

Frontiers in Oncology(2022)10.3389/fonc.2022.890154

N/A

0DataRank · unranked

41 citations

Aaron Lindstrom, Edward Kim, Chang‐Il Hwang, Madison Lee Hall, Tzu‐yin Lin +2 more

Neural KEM: A Kernel Method With Deep Coefficient Prior for PET Image Reconstruction

IEEE Transactions on Medical Imaging(2022)10.1109/tmi.2022.3217543

N/A

0DataRank · unranked

20 citations

Kuang Gong, Ramsey D. Badawi, Edward Kim, Jinyi Qi, Guobao Wang +1 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

705 Immunosuppressive CD14 + monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0705

N/A

0DataRank · unranked

0 citations

Bridget P. Keenan, Bryan Le, Quincy Harris, J.J. Chen, Matthew D. Clark +12 more

Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

European Journal of Cancer(2020)10.1016/j.ejca.2020.01.026

N/A

0DataRank · unranked

43 citations

Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii‐Saab, Stacey Stein, Vaibhav Sahai +9 more

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer

The Oncologist(2025)10.1093/oncolo/oyaf400

N/A

0DataRank · unranked

0 citations

Shannon Stockton, Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward Kim +12 more

MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis

Molecular Pharmacology(2020)10.1124/molpharm.120.000130

N/A

0DataRank · unranked

36 citations

Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J. Bold, Frank J. Gonzalez +3 more